Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Users Online: 601 | Home Print this page Email this page Small font size Default font size Increase font size
Year : 2012  |  Volume : 32  |  Issue : 5  |  Page : 14

OA01.14. Efficacy of gorakhmundi In obesity: A single-blind placebo-controlled study

Dravyaguna, Govt. Ayurveda College, Nagpur, Maharashtra, India

Correspondence Address:
Madhuri Hemant Wagh
Dravyaguna, Govt. Ayurveda College, Nagpur, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Purpose : Obesity, the state of excessive adipose tissue, with increased morbidity, mortality from numerous diseases nearly in a pandemic stage; necessitates urgent search for safe, effective anti-obesity medications, as extant modern drugs have significant major adverse effects. Charaka elaborated very lucidly qualitative signs & symptoms of obesity (Sutrasthan A21). Gorakhmundi (Sphaeranthus indicus), a widely available seasonal wild herb, called Som-Sum-Veerya (Sushruta), Palankash (weathers fat away; Shaligram), Mundi (beheads diseases), anti-obesity effects mentioned in seven Nighantu(s); thus holds promise. This study evaluates its anti-obesity efficacy using single-blind, placebo-controlled design. Method: Forty persons (age 25-50 yrs), 20 each in study and control groups, with weight >10kg excess than LIC actuarial mean normal, evaluated at baseline using BMI, Waist/Hip Ratio, skin-fold thickness at Biceps, Triceps, Sub-scapular & Supra-iliac sites and also 23 qualitative criteria collated from Ayurveda's Classical Texts; were administered for 90 days at 2gm/day dose either Gorakhmundi Panchang-Choorna or Spinach Choorna respectively and reassessed monthly. Anthropometric measurements analysed using descriptive statistics & paired t test. Qualitative criteria- descriptive statistics. Result : At 90 days, Study Group shows -->5% weight reduction in 45%, 3-5% in 45%, 0.334/week or 1.34/month, Highly Significant- weight reduction, p<0.001, - Improvement in- BMI, p<0.001; W/H Ratio, p<0.001; -- Skin-fold Triceps, Subscapular, Suprailiac, p<0.001, (Biceps p<0.05), Qualitative features viz. Body Mal-odor, Hyper-sweating, heaviness, slackness, lack of swiftness, laziness, exercise intolerance, deep breathing discomfort, excessive thirst showed considerable improvement in majority persons showing these at baseline. Conclusion: Study confirms Gorakhmundi's significant anti-obesity efficacy, using single-blind placebo-control design and modest sample.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded76    
    Comments [Add]    

Recommend this journal